A carregar...
TAM receptors Tyro3 and Mer as novel targets in colorectal cancer
PURPOSE: CRC remains the third most common cancer worldwide with a high 5-year mortality rate in advanced cases. Combined with chemotherapy, targeted therapy is an additional treatment option. However as CRC still escapes targeted therapy the vigorous search for new targets is warranted to increase...
Na minha lista:
| Formato: | Artigo |
|---|---|
| Idioma: | en |
| Publicado em: |
Impact Journals LLC
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5302919/ https://ncbi.nlm.nih.gov/pubmed/27486820 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10889 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|